Advocacy intelligence hub — real-time data for patient organizations
BabyBIG: FDA approved
Indicated for treatment of infant botulism caused by type A or type B Clostridium botulinum.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
BabyBIG
California Department of Public Health
BabyBIG
(Botulism immune globulin)Orphan drugCalifornia Department of Public Health
Human Immunoglobulin G [EPC]
12.1 Mechanism of Action BabyBIG contains antibodies specific for botulinum neurotoxin types A and B that bind to and neutralize circulating toxin typ...
Haydee A Dabritz
Infant Botulism Treatment and Prevention Program
Jessica M Khouri
Infant Botulism Treatment and Prevention Program
Jason R Barash
Infant Botulism Treatment and Prevention Program
Nir Dover
Infant Botulism Treatment and Prevention Program
Richard A Harris
Botulism Reference Service for Canada
Bar Goldberg